Drugs / Chang Ji'an Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07610434 | May 2026 → Jan 2028 expected | irritable bowel syndrome | Beijing Hospital of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chang Ji'an Capsules | “Chang Ji'an Capsules, 4 capsules each time, 3 times a day, orally” NCT07610434 ↗ |
| Known as | Chang Ji'an capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07610434 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The prescription consists of 13 medicinal ingredients including Radix Paeoniae Alba, Rhizoma Atractylodis Macrocephalae (processed), and Radix Astragali.” NCT07610434 ↗ |
| Route | Oral | “4 capsules each time, 3 times a day, orally” NCT07610434 ↗ |